Children's Panadol is being pulled from shelves, with the national drug regulator warning batches contaminated with invisible fibres could prompt allergic reactions.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
Three batches of strawberry and orange flavoured Panadol for children aged five to 12 years, supplied in 200ml bottles, are being recalled from pharmacies and wholesalers by manufacturer GlaxoSmithKline Consumer Healthcare Australia.
The Therapeutic Goods Administration said in a statement on Thursday that an ingredient in the medicine "may have been contaminated with small particles that could contain trace minerals and inert fibres."
"If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time."
The particles may not be visible, and would be low in number, it said.
The TGA warned customers not to use Children's Panadol they had bought if their bottle was from one of the affected batches, which were numbered 136418, 136444 and 136443. All the affected products have an expiry date of February 2018.
It said customers should check the label on the bottle of Panadol or the bottom of its packaging for the batch number.
"No other batches, bottle sizes or products are affected by this recall," it said.
